MentionFox
Home › funding signals › Gossamer Bio, Inc. › competitors
Competitors and similar companies

Gossamer Bio, Inc.'s competitors and similar companies

The 4 nearest raises on the records held here, in the same industry group (Biotechnology), side by side with Gossamer Bio, Inc..

Back to the full Gossamer Bio, Inc. record.

75% percentile
$25M
of raises in its group are smaller

Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.

Offering size, this raise against its peers
Superluminal Medicines, Inc.
$65.48M
Gossamer Bio, Inc.
$25M
Episteme Prognostics, Inc.
$5.09M
Episteme Prognostics, Inc.
$5.09M
Pluri Inc.
$3.68M

Bars are to scale against $65.48M, the largest of the six. The dotted line is the median of all 5 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.

Company On the record Industry group Filed
Episteme Prognostics, Inc.$5.09MBiotechnology2026-09-04
Episteme Prognostics, Inc.$5.09MBiotechnology2026-09-04
Pluri Inc.$3.68MBiotechnology2026-09-04
Superluminal Medicines, Inc.$65.48MBiotechnology2026-09-03
Gossamer Bio, Inc. (this page)$25MBiotechnology2026-09-04

Click a column heading to sort. Comparison is against records held here, not against every raise that exists. A raise with no stated amount shows as "Not stated" rather than as zero.

How this list is chosen

Nearest by stated offering size, inside the industry group the filing itself declares (Biotechnology). Nothing is inferred about what a company does.

Comparison is against records held here, not against every raise that exists. Figures are read directly from the source record; names have not been matched against other people.